Latest Research in Platelet Disorders and Treatments
15 research papers · 2026 median publication year
Top Research Topics in Platelet Disorders and Treatments
- Hemophilia Treatment and Research — 10 papers
- Platelet Disorders and Treatments — 1 papers
- Complement system in diseases — 1 papers
- Barrier Structure and Function Studies — 1 papers
- Coagulation, Bradykinin, Polyphosphates, and Angioedema — 1 papers
- Transplantation: Methods and Outcomes — 1 papers
Highest-Cited Papers
- Analysis of Annual Global Survey Reports for Haemophilia B in the Eastern Mediterranean Region: Disparities in Trends for A decade (2014–2023)
- DDAVP Challenges in 170 Children With von Willebrand Disease: Response Classification Varies According to Criteria Used
- Congenital Hemophilia‐A With High‐Titer Inhibitor and Essential Thrombocythemia: A Rare Coexistence
- From Biological Insight to a New Class of Medicines for Hemophilia A
- Deficiency of high‐molecular‐weight von Willebrand factor mitigates thrombo‐complement injury in an LPS‐induced TMA‐like mouse model
- Factor VIII inhibitors demonstrate type I or type II kinetics in high‐titre alloantibodies and autoantibodies
- Akhirin Preserves Hemostatic Wound Repair Through Non-Hematopoietic Regulation of the Vascular Injury Microenvironment
- Utilizing Inhibitor Screening Assay Results to Predict Bethesda Titers in Patients With Hemophilia A: Cost‐Effective Strategy in Resource‐Constrained Setting
- Use of C1 Inhibitor Subcutaneously in the United Kingdom: Insights from a National Real-World Retrospective Study
- Acquired hemophilia: insights from a multicenter real-life study in a middle-income country
- Single versus double lung transplantation in patients with pneumoconiosis: a retrospective cohort study
- Prediction of coagulation factor inhibitor levels using Random Forest model based on the activated partial thromboplastin time (aPTT) mixing study: model development and prototype application
- Population‐Level Real‐World Healthcare Costs in Men and Women With Haemophilia A
- Whole genome sequencing to elucidate novel genetic modifiers of FVIII clearance.
- Persistent Hypersensitivity Reactions Associated With Anti‐PEG IgM Antibodies During On‐Demand Therapy With PEGylated Factor VIII in Mild Hemophilia A